ALKERMES
Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, chronic diseases. Alkermes, Inc. develops, manufactures and commercializes VIVITROL for alcohol dependence and manufacture RISPERDAL CONSTA for schizophrenia and bipolar I disorder. Its pipeline includes extended-release injectable and oral products for the treatment of prevalent, chronic diseases, such as central... nervous system (CNS), disorders, reward disorders, addiction, diabetes and autoimmune disorders. The Company has a research facility in Massachusetts and a commercial manufacturing facility in Ohio. RISPERDAL CONSTA is used for the treatment of schizophrenia and for the treatment of bipolar I disorder. VIVITROL is an extended-release MEDISORB formulation of naltrexone, as a once-monthly injectable medication for the treatment of alcohol dependence.
ALKERMES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1987-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.alkermes.com
Total Employee:
1001+
Status:
Active
Contact:
+353 1 772 8000
Email Addresses:
[email protected]
Total Funding:
250 M USD
Technology used in webpage:
Domain Not Resolving Apple Mobile Web Clips Icon Amazon Mobile Non Scaleable Content Nginx Cloudflare Hosting Cloudflare CDN Google Google Cloud DNSSEC
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Evox Therapeutics
Evox Therapeutics is a biotechnology company that harnesses and engineer the natural trafficking capabilities of extracellular vesicles.
MediGene
MediGene is a company that specializes in biotechnology specifically in the treatment of cancer.
Noema Pharma
Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-18 | Rodin Therapeutics | Rodin Therapeutics acquired by Alkermes | N/A |
| 1999-07-13 | Advanced Inhalation Research | Advanced Inhalation Research acquired by Alkermes | N/A |
| 1993-01-01 | Enzytech | Enzytech acquired by Alkermes | N/A |
Investors List
Primecap Management
Primecap Management investment in Post-IPO Equity - Alkermes
Invesco
Invesco investment in Post-IPO Equity - Alkermes
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-11-15 | Mural Oncology | Alkermes investment in Corporate Round - Mural Oncology | 275 M USD |
| 2023-08-31 | She Recovers Foundation | Alkermes investment in Grant - She Recovers Foundation | N/A |
| 2023-08-31 | NAMI Mobile | Alkermes investment in Grant - NAMI Mobile | N/A |
| 2023-08-31 | American Psychiatric Association | Alkermes investment in Grant - American Psychiatric Association | N/A |
| 2023-08-31 | CSG Justice Center | Alkermes investment in Grant - CSG Justice Center | N/A |
| 2023-08-31 | The Recovery Community Network | Alkermes investment in Grant - The Recovery Community Network | N/A |
| 2023-08-31 | Caregiver Action Network | Alkermes investment in Grant - Caregiver Action Network | N/A |
| 2023-08-31 | Foundation for Women's Cancer | Alkermes investment in Grant - Foundation for Women's Cancer | N/A |
| 2023-08-31 | Ohio Chamber of Commerce Research Foundation | Alkermes investment in Grant - Ohio Chamber of Commerce Research Foundation | N/A |
| 2023-08-31 | Cancer Legal Care | Alkermes investment in Grant - Cancer Legal Care | N/A |
Newest Events participated
Participated in The Next Era in Innovation
on 2017-04-13 as sponsor
Official Site Inspections
http://www.alkermes.com Semrush global rank: 1.37 M Semrush visits lastest month: 18.93 K
- Host name: 72.32.33.202
- IP address: 72.32.33.202
- Location: San Antonio United States
- Latitude: 29.4963
- Longitude: -98.4004
- Metro Code: 641
- Timezone: America/Chicago
- Postal: 78218
More informations about "Alkermes"
About Alkermes | Alkermes
Alkermes is committed to diversity, inclusion and belonging (DIB) in various aspects of our business. We strive to foster an environment of equality and compassion, where all voices are respected and valued. It is important to our …See details»
Diversity, Inclusion & Belonging - Alkermes
Alkermes is committed to diversity, inclusion and belonging in all aspects of our business. We strive for an environment fostering equality and compassion. ... play important roles in helping to ensure our efforts are aligned with the diverse …See details»
Alkermes plc - Wikipedia
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturi…See details»
Alkermes - Crunchbase Company Profile & Funding
Alkermes, Inc. is an integrated biotechnology company. The Company is engaged in the business of developing, manufacturing and commercializing medicines for the treatment of prevalent, …See details»
Alkermes - The Org
Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions.See details»
Alkermes - LinkedIn
Alkermes | 58,635 followers on LinkedIn. Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. | At Alkermes, we apply our deep ...See details»
Alkermes - LinkedIn
Alkermes | 55,072 followers on LinkedIn. Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. | At Alkermes, we apply …See details»
Alkermes Corporate Responsibility | Alkermes
Alkermes engages with health-related, industry and public policy organizations to advance common goals central to our mission. A selection of our current corporate memberships is available using the link below. View Memberships. …See details»
Org Chart Alkermes - The Official Board
The organizational chart of Alkermes displays its 51 main executives including Richard Pops, Iain Brown and Blair Jackson. Toggle navigation The Official Board. Search. Search. Search by segment. Sign In. Business E-mail* …See details»
Alkermes (company) - Wikipedia
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by …See details»
Alkermes - Contacts, Employees, Board Members, Advisors & Alumni
Alkermes has 5 current employee profiles, including CMO and Head of Clinical Development and Medical Affairs Craig Hopkinson. Alkermes has 12 board members and advisors, including …See details»
Alkermes: Advancing Key Business Priorities in 2022
Alkermes field organization calls on focused healthcare provider universe, prioritized for high-potential prescribers of branded oral antipsychotics: Prescribes olanzapine: Utilizes branded …See details»
Alkermes Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Alkermes is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global …See details»
Great Science. ompassion. - Alkermes
Organization strategically, sustainably and responsibly. Alkermes respects the culture, customs and values of the people in the communities in which we work and live. We seek to support …See details»
Alkermes - Overview, News & Similar companies | ZoomInfo.com
Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Read more. Alkermes's Social Media. Is this data correct? View contact profiles from Alkermes. Popular …See details»
Alkermes, continuing transformation, plans to split in two
Nov 2, 2022 Alkermes said the new company’s leadership team will be disclosed at a later date and that the separation, if successful, should close by the second half of 2023. Dive Insight: …See details»
Our Stories - Alkermes
Our mission and values come to life through our people, our progress and our impact. These stories highlight the unique qualities of who we are today, what we are working on and where …See details»
Investors | Alkermes plc
Oct 24, 2024 Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary …See details»
News & Events - Alkermes
Nov 7, 2024 Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A …See details»